# Trial of Laryngeal Preservation Comparing Induced CT Followed by RT vs CT Concomitant to RT

> **NCT03340896** · PHASE3 · ACTIVE_NOT_RECRUITING · sponsor: **Groupe Oncologie Radiotherapie Tete et Cou** · enrollment: 256 (actual)

## Conditions studied

- Head and Neck Squamous Cell Carcinoma

## Interventions

- **DRUG:** Docetaxel
- **DRUG:** Cisplatin
- **DRUG:** Fluorouracil
- **RADIATION:** radiotherapy

## Key facts

- **NCT ID:** NCT03340896
- **Lead sponsor:** Groupe Oncologie Radiotherapie Tete et Cou
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2015-06-25
- **Primary completion:** 2028-10
- **Final completion:** 2028-11
- **Target enrollment:** 256 (ACTUAL)
- **Last updated:** 2025-09-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03340896

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03340896, "Trial of Laryngeal Preservation Comparing Induced CT Followed by RT vs CT Concomitant to RT". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT03340896. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*